President’s 2024 Budget builds on important drug pricing reforms passed in the Inflation Reduction Act of 2022 WASHINGTON–(BUSINESS WIRE)–AIDS Healthcare Foundation (AHF) applauds President Biden’s continued efforts to lower prescription drug prices for all Americans. The President’s 2024 budget will build on the important drug pricing reforms passed in the Inflation Reduction Act, according to … [Read more…]
VANCOUVER, British Columbia–(BUSINESS WIRE)–Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating neurodegenerative disorders, today reported financial results for the fourth quarter and full year ended December 31, 2022 and provided a corporate … [Read more…]
NEW BRUNSWICK, N.J.–(BUSINESS WIRE)–Johnson & Johnson (NYSE: JNJ) today announced that Kenvue Inc. (“Kenvue”), a wholly owned subsidiary of Johnson & Johnson, priced an offering of the following series of senior unsecured notes in an aggregate principal amount of $7.75 billion (each series of notes collectively, the “Notes”): Principal Coupon Maturity Date $750,000,000 5.500% Senior … [Read more…]
FORT LAUDERDALE, Fla.–(BUSINESS WIRE)–$MD–Pediatrix Medical Group, Inc. (NYSE: MD) today announced that its board of directors has elected James D. Swift, M.D., the Company’s chief executive officer, as a director effective March 8, 2023. This appointment fills a seat previously held by Roger J. Medel, M.D. “Jim’s election follows his recent appointment as chief executive … [Read more…]
BIRMINGHAM, Ala.–(BUSINESS WIRE)–Today the board of directors of ProAssurance Corporation (NYSE:PRA) declared a cash dividend of $0.05 per common share, payable on April 13, 2023 to shareholders of record as of March 29, 2023. Our dividend policy anticipates a total annual dividend of $0.20 per share paid in equal quarterly installments. However, any decision to … [Read more…]
BURLINGTON, Mass.–(BUSINESS WIRE)–Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”), a digital health company transforming care with handheld, whole-body ultrasound, today announced that it will participate in the 33rd Annual Oppenheimer Healthcare Conference taking place virtually on March 13-15, 2023. Heather Getz, Executive Vice President & Chief Financial Officer, Darius Shahida, Chief Strategy Officer & Chief Business … [Read more…]
CRYSTAL LAKE, Ill.–(BUSINESS WIRE)–AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, has been named one of Barron’s 100 Most Sustainable Companies for the fifth consecutive year and is ranked number 55 out of 100 companies for 2023. “As a company committed to a … [Read more…]
BILLERICA, Mass.–(BUSINESS WIRE)–Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that Chief Executive Officer Masoud Toloue will present at Barclays Global Healthcare Conference on Wednesday, March 15, 2023 at 4:35 p.m., EDT. In addition, the company will also host in-person one-on-one meetings with institutional investors on March 15. … [Read more…]
GAINESVILLE, Fla.–(BUSINESS WIRE)–Evanoa Bioscience Inc., a cell line developer for biologics manufacturing, together with Aldevron®, a global leader in the custom development and manufacture of plasmid DNA, RNA and proteins for the biotech industry, today announced the signing of a licensing agreement for two E. coli strains to be used in plasmid production. Evanoa is … [Read more…]
MAHWAH, N.J.–(BUSINESS WIRE)–KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use subcutaneous drug delivery systems that improve quality of life for patients, today reported financial results for the fourth quarter and full year ended December 31, 2022. … [Read more…]
